Interest Paid, Excluding Capitalized Interest, Operating Activities in USD of Tonix Pharmaceuticals Holding Corp. from 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from 2023 to Q1 2025.
  • Tonix Pharmaceuticals Holding Corp. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Mar 2025 was $117,000.
  • Tonix Pharmaceuticals Holding Corp. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $1,234,000, a 1302% increase from 2023.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)

Tonix Pharmaceuticals Holding Corp. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $117,000 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1

Tonix Pharmaceuticals Holding Corp. Annual Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1,234,000 +$1,146,000 +1,302% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
2023 $88,000 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.